Amedra Pharmaceuticals, headquartered in Horsham, Pennsylvania, is focused on delivering mature branded prescription products in the United States market through acquisition, licensing, and product development. Key products include Dexedrine®, Albenza®, Daraprim® and Twinject/Adrenaclick®. In addition, the company owns one ANDA drug product.
View Top Employees from Amedra Pharmaceuticals LLC| Website | https://www.amedrapharma.com |
| Revenue | $4 million |
| Employees | View employees |
| Phone | (215) 259-3601 |
| Fax | (215) 674-9817 |
| Industry | Pharmaceuticals, Drug Manufacturing & Research, Healthcare |
| Competitors | Ambrx, Aprecia Pharmaceuticals, Lexicon Pharmaceuticals, Inc., Surface Oncology Inc., TruTag Technologies, Inc. |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Amedra Pharmaceuticals LLC employee's phone or email?
Amedra Pharmaceuticals LLC Questions
The Amedra Pharmaceuticals LLC annual revenue was $4 million in 2023.
Amedra Pharmaceuticals LLC is based in Horsham, Pennsylvania.
The NAICS codes for Amedra Pharmaceuticals LLC are [3254, 32541, 325, 32].
The SIC codes for Amedra Pharmaceuticals LLC are [28, 283].
Related Companies
